By Dr Zhong Zhong (Ovid)2024-05-17T09:09:06
Neuroscientists are increasingly viewing disorders of the brain through the lens of the underlying molecular mechanisms as sometimes illuminated by genetic variants, rather than classifying disorders based solely on the clinical symptoms. The next step in the evolution of antiseizure medication will likely come from studying these ...
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2023-04-12T15:28:08
Sponsored by nanoComposix
2024-02-08T11:07:39
Sponsored by Samplix ApS
2024-03-08T10:00:25
Sponsored by Molecular Devices
2023-05-23T11:10:47
Sponsored by NanoTemper Technologies
2024-01-10T08:23:16
Sponsored by BellBrook Labs
2026-03-25T15:00:00 2026-03-25T16:00:00
Sponsored by Yokogawa
Site powered by Webvision Cloud